GLAXO.NS
GLAXO.NS
INE159A01016
GLAXOSMITHKLINE PHARMA LT
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
430.34B EUR
415.12B EUR
386.75B EUR
Enterprise Value
403.11B EUR
415.12B EUR
376.07B EUR
Valuation Multiples
Trailing P/E
40.19x
40.87x
37.14x
Forward P/E
32.08x
--
--
Price to Sales
10.88x
10.98x
10.13x
Price to Book
18.98x
--
17.06x
EV/Revenue
10.19x
10.98x
9.85x
EV/EBITDA
30.31x
29.14x
25.77x
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
--
--
--
ende